Copyright: ©Author(s) 2026.
World J Stem Cells. Jun 26, 2026; 18(6): 119550
Published online Jun 26, 2026. doi: 10.4252/wjsc.119550
Published online Jun 26, 2026. doi: 10.4252/wjsc.119550
Table 4 Cox regression analysis for influence on disease-free survival
| Variables | Univariate HR (95%CI) | P value | Multivariate HR (95%CI) | P value |
| TNM stage II (vs stage I) | 1.320 (0.900-1.930) | 0.150 | 1.180 (0.830-1.680) | 0.350 |
| TNM stage III (vs stage I) | 2.100 (1.450-3.040) | < 0.001 | 1.740 (1.210-2.510) | 0.003 |
| Poorly differentiated | 1.400 (1.010-1.950) | 0.043 | 1.150 (0.810-1.630) | 0.430 |
| CD133 high expression | 1.280 (0.950-1.730) | 0.100 | 1.120 (0.840-1.500) | 0.410 |
| ALDH1A1 high expression | 1.460 (1.060-2.010) | 0.020 | 1.350 (1.000-1.820) | 0.048 |
| SOX2 high expression | 1.200 (0.920-1.580) | 0.190 | 1.050 (0.800-1.380) | 0.780 |
| High CSC group (2-3 points) | 1.600 (1.150-2.230) | 0.006 | 1.420 (1.040-1.930) | 0.028 |
- Citation: Luo LL, Jiang SC, Li S, Zhang GY, Tang JJ, Guo YD. Cancer stem cell-associated markers and their prognostic value in non-small cell lung cancer. World J Stem Cells 2026; 18(6): 119550
- URL: https://www.wjgnet.com/1948-0210/full/v18/i6/119550.htm
- DOI: https://dx.doi.org/10.4252/wjsc.119550